$2.670
-0.124 (-4.64%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de OVID por análisis de gráficos similares
Alphio's OVID stock price prediction model matches the current Ovid Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.65 (-0.66%). The 1-week path is $2.70 (+1.21%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Ovid Therapeutics Inc?
Ovid Therapeutics Inc is a good buy right now due to its current price of $2.80, which is significantly below the analyst price target of $7, indicating a potential upside of 150%. Additionally, the company has a strong cash position of $165.6 million, which supports ongoing R&D efforts, and a gross margin of 100% in recent quarters, showcasing its ability to maintain profitability on sales. However, a key risk is the negative net income reported, which was -$15 million in Q2 2026, indicating ongoing losses that investors should monitor closely.
OVID cerró en $2.67 el Monday, tras bajar -4.64%
Ovid Therapeutics Inc (OVID) last closed at $2.67, losing -4.64%. These facts feed the 1-day and 1-week OVID price prediction above.
Consenso de analistas
Ovid Therapeutics Inc (OVID): 4 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Ovid Therapeutics Inc (OVID) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de OVID, ordenadas por similitud.
Análisis de estacionalidad de OVID
Historically the probability of a positive September return for OVID is 52.38%. September offers the highest probability of a positive month at 52.38%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de OVID
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $0.21 | $0.25 | $0.26 | -90.58% |
| Oct 2026 | $0.29 | $0.29 | $0.31 | -88.96% |
| Nov 2026 | $0.23 | $0.27 | $0.30 | -90.03% |
| Dec 2026 | $0.25 | $0.27 | $0.29 | -89.72% |
En 2026, se proyecta que Ovid Therapeutics Inc (OVID) oscile entre $0.21 y $0.31.
Previsión mensual de Ovid Therapeutics Inc para 2026
En Sep de 2026, se proyecta que Ovid Therapeutics Inc promedie $0.25, con un mínimo de $0.21 y un máximo de $0.26.
En Oct de 2026, se proyecta que Ovid Therapeutics Inc promedie $0.29, con un mínimo de $0.29 y un máximo de $0.31.
En Nov de 2026, se proyecta que Ovid Therapeutics Inc promedie $0.27, con un mínimo de $0.23 y un máximo de $0.30.
En Dec de 2026, se proyecta que Ovid Therapeutics Inc promedie $0.27, con un mínimo de $0.25 y un máximo de $0.29.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.